A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

NCT00730639 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostrate Cancer
Renal Cell Carcinoma
Metastatic Melanoma
Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: BMS-936558 (MDX-1106)
BIOLOGICAL: BMS-936558 (MDX-1106)
BIOLOGICAL: BMS-936558 (MDX-1106)
BIOLOGICAL: BMS-936558 (MDX-1106)
BIOLOGICAL: BMS-936558 (MDX-1106)

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]